1. Versatile hyaluronic acid modified AQ4N-Cu(II)-gossypol infinite coordination polymer nanoparticles: Multiple tumor targeting, highly efficient synergistic chemotherapy, and real-time self-monitoring
   Shihong Shen et al, 2018, Biomaterials CrossRef
2. Hypoxia-activated prodrugs
   Wagdy M. Eldehna, 2025, Advances in Prodrugs CrossRef
3. Novel Anthraquinone Compounds as Anticancer Agents and their Potential Mechanism
   Wei Tian et al, 2020, Future Medicinal Chemistry CrossRef
4. AQ4N nanocomposites for hypoxia-associated tumor combination therapy
   Amrah Inam et al, 2024, Biomaterials Science CrossRef
5. Targeting Hypoxia: Hypoxia-Activated Prodrugs in Cancer Therapy
   Yue Li et al, 2021, Frontiers in Oncology CrossRef
6. TargetingDNAtopoisomeraseIIα(TOP2A) in the hypoxic tumour microenvironment using unidirectional hypoxia‐activated prodrugs (uHAPs)
   Paul J. Smith et al, 2023, IUBMB Life CrossRef
7. Exploring hypoxic biology to improve radiotherapy outcomes
   Chun Li et al, 2022, Expert Reviews in Molecular Medicine CrossRef
8. Hypoxia-targeted drug delivery
   Amit Sharma et al, 2019, Chemical Society Reviews CrossRef
9. Combinatory anti-tumor activities of 1,4-bis[2-(dimethylamino)ethylamino]-5,8-dihydroxyanthracene-9,10-dione (AQ4) and temsirolimus against colorectal cancer cells
   Kazuaki Okamoto et al, 2023, Journal of Cancer Research and Clinical Oncology CrossRef